Delivery Order SPE2DB22D3004-SPE2DB24FPF85

Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $6.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,554.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, with a performance period ending on February 28, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award did not have any set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award, valued at $16,045.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under a broader Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract is for the provision of 4555058987 - NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The award, valued at $5,183.25, is a delivery order contract with a firm fixed price. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 1, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $16,243.75, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has an ultimate completion date of May 16, 2023 and is a Firm Fixed Price Delivery Order. The contract is not set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp is a major...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML. The contract has a ceiling value of $11,218.40 and runs through December 1, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of 240mL bottles of the pharmaceutical drug Nitrofurantoin 25mg/5mL suspension to the Defense Logistics Agency (DLA). The contract, valued at $6,726.90, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026. This...
This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award has a ceiling value of $19,139.80 and a period of performance through September 28, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $26,116.35 for the supply of 4,562,252 units of NITROFURANTOIN MONO-MCR 100 MG. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 21, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, with an ID of SPE2DX15D1021|SPE2DX24FHQMA, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563803522 - Nitrofurantoin 25 mg/5 ml suspension, 240 ml, with a ceiling value of $11,273.91 and an ultimate completion date of February 29, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds...
This federal contract award, valued at $30,697.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,182,939 units of Nitrofurantoin Mono-MCR 100 mg medication to support federal healthcare programs. The award is a firm-fixed-price delivery order with a completion date of December 28, 2023. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FPF85
    Delivery Order

This federal contract award, valued at $6,372.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563585214 - NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product.

The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp, the prime contractor, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.

Generated 5/14/25, 9:51 AM